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Abstract
Transdermal drug delivery (TDD) is a painless method of low-dose drug delivery. The
advantages and disadvantages of transdermal drug delivery methods are named and
basic methods such as using chemical enhancers, iontophoresis and electrophoresis are
introduced. One of the promising methods make use of plasma which is generated in
atmospheric pressure mostly in volume or on surface dielectric barrier discharge (DBD)
or in plasma jet. As the plasma produces various particles according to the used gas,
UV  radiation  and  heat,  their  effects  on  skin  and  barrier  function  are  described.
Improvement of transdermal drug delivery of hydrophilic drug galantamine hydro-
bromide (GaHBr) using microplasma electrode is introduced.
Keywords: microplasma, plasma jet, plasma drug delivery, skin, stratum corneum
1. Introduction of atmospheric plasma for medical application
Medical applications of atmospheric plasma have been intensively studied [1]. These studies
have reported numerous applications, such as for sterilization [2, 3], decomposition of harmful
substances [4] and surface treatments [5–7]. In recent years, this area of research has been focused
on the practical utilization of atmospheric plasma in the medical filed, such as for blood
coagulation [8, 9], wound healing [10–12] and cancer treatment [13–15]. On the other hand,
dermatology is one area of medicine where atmospheric plasma applications are currently used
in practice [16], such as in a device to treat acne or wrinkles [17] and to treat stretch marks in
combination with ultrasonic waves [18, 19]. As explained above, various research and devel-
opment efforts have been conducted in the application of plasma medicine; however, we do not
yet know whether plasma irradiation can be used to treat various symptoms. Though, the basic
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mechanisms of cell response [13–15] and the bacterial sterilization process [2, 3] have been
studied intensively, effectiveness of plasma medicine in treating depression, which is a social
problem in contemporary countries such as Japan, and Alzheimer’s disease,  which is an
increasing problem in aging societies, has not still been investigated. The use of plasma medicine
to treat various other diseases, such as cerebral infarction and high blood pressure, also requires
additional investigation. Reactive oxygen species (ROSs) and reactive nitrogen species (RNSs)
could play important roles in the beneficial effects of plasma medicine. Mechanisms underlying
these effects could be quite complicated because of the physiological activation in the body by
ROS signalling [20]. Fundamental research to elucidate the cellular response is currently under
investigation. In contrast, reactive species generated in plasma or exposed liquid medium have
demonstrated efficacy for treating various cancers, but not for the previously mentioned mental
disorders, other associated symptoms or diseases such as diabetes, cerebral infarction and high
blood pressure [21]. Fortunately, mechanisms of depression and Alzheimer’s disease have been
revealed in detail. The inhibited production of neurotransmitters (serotonin, noradrenalin and
dopamine) causes depression, and Alzheimer’s disease occurs because of the deposition of a
peptide called amyloid-ß on the cerebral cortex. Research and development of effective drugs
for treating mental disorders are proceeding [22]. These drugs are administrated orally; however,
the effects of many of these drugs are delayed because of absorption in the small intestine.
Moreover, as is the case with oral administration, absorption of drugs in additional locations is
different for each person. Thus, administration by injection is used if a precise or high dose of
drugs is needed [23, 24]. Administration of poorly absorbed drugs is also the same. However,
frequent injections are not desirable in the view of a patient’s quality of life (QOL). We can point
out the following questions to guide the future of plasma medicine and develop it into a strong
tool for the treatment of various symptoms:
1. Is plasma medicine an effective method for treating various symptoms?
2. If not, what combination of drugs in addition to plasma irradiation will be required?
3. Can plasma irradiation be an effective method for drug administration?
As mentioned in many of the references, recent studies of plasma medicine are mostly focused
on direct or indirect actions of the active species. Hence, clinical cases, such as Alzheimer’s
disease, diabetes, cerebral infarction and high blood pressure, have not yet been investigated
to determine whether reactive species and plasma medicine could be an effective treatment.
Applying plasma medicine for treatment of various symptoms, we have been considering
plasma irradiation as a method to deliver appropriate drugs [25]. One instance of this use is
the enhancement of percutaneous absorption by atmospheric microplasma irradiation.
Percutaneous absorption is a drug administration method in which drugs are absorbed into
the skin or body. In this sense, this method is similar to an injection; however, there is no need
for a needle in plasma irradiation. Administering drugs in ways that do not require needles
could increase patient QOL and reduce the rate of infections. In addition, percutaneous
absorption has several advantages, such as preventing metabolism of the drug [24] and
stabilizing the concentration of drug in the blood [26]. However, it has disadvantages as well,
such as the limitation of the molecular weight of the drug [27] and the need for moderate
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solubility of the drug in lipids [28]. The stratum corneum layer inhibits drug penetration
because the skin acts as a barrier to guard our body from foreign substances.
2. Advantages and disadvantages of TDD
Transdermal drug delivery (TDD) is an alternative to oral and parenteral routes of adminis-
tration. It can offer some advantages over other methods of drug delivery [29, 30]:
1. Reduction of dosing frequency, due to longer duration of delivery.
2. Lower dosing of drugs.
3. Circumvention of first-pass inactivation by liver that can metabolize drugs.
4. Reduction of gastrointestinal irritation.
5. Lower probability of over or under dosing.
6. No pain.
7. No risk of infection by a contaminated needle or via wounds caused by a needle.
8. Suitable for patients with problems of swallowing.
Disadvantages of TTDS:
1. Only some drugs are permeable through the skin.
2. Limited to drugs with a daily dose 10 mg and less.
3. Slow drug delivery.
4. Possible skin irritation.
3. Stratum corneum structure
Stratum corneum, an upper layer of the skin, is a lipid-rich matrix with embedded corneocyte
cells, which are dead keratinocytes. Corneocytes are tied together by a protein called corneo-
desmosome (Figure 1). Renewal of stratum corneum occurs every 14 days [31]. This layer is
the first barrier for transdermal drug delivery. Lipid-rich matrix is used for transdermal drug
delivery (TDD)—intercellular pathway. The lipid-rich matrix is composed of hydrophilic
domain—head of ceramides and lipophilic domain—tails (Figure 1). The lipids in stratum
corneum include mostly ceramides (41%), cholesterol (27%), cholesteryl esters (10%) and fatty
acids (9%) with a small fraction of cholesterol sulphate (2%) [32]. The presence of ceramides
indicates that lipids will be structured [31].
The permeability of stratum corneum lipid membranes depends strongly on the ceramide
composition of these membranes. Molecular dynamics simulations show that ceramides with
shorter (four- to eight-carbon acyl chains) fatty acid chains increase skin permeability, whereas
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further shortening of the chain leads to increased resistance to penetration almost as good as
that of ceramides from healthy skin (24 carbons long on average) [33]. In order to enhance skin
permeability, mechanisms like alternation of lipids of stratum corneum and its fluidity or
creation of the disordering effect between alkyl chains of lipids of stratum corneum have been
proposed [34].
Figure 1. Stratum corneum layer with intercellular space [31].
4. Diagnostics of barrier properties of the skin—TEWL (transepidermal
water loss), TST (tape stripping test), ATR-FTIR (attenuated total
reflection-Fourier transform infrared spectroscopy)
There are wide varieties of methods available for analysing skin structure and other properties
including its barrier function, such as Raman spectroscopy [35], X-ray diffraction [36], electron
diffraction [37] and transmission electron microscopy [38]. Barrier properties of the stratum
corneum can be confirmed by the transepidermal water loss (TEWL) test, which indicates water
evaporation from the inner body through skin [21]. This test expresses the amount of water in
grams evaporated per square metre in 1 h. Stratum corneum is a barrier against water diffusion
and some other chemicals. The better the barrier function of the skin, the higher the water
content and the lower the TEWL value. The tape striping test was described for the first time
by Pinkus [39] in 1951. This method is based on removing of stratum corneum layers of the
skin. The amount of removed stratum corneum is not constant and it depends on many
parameters such as cohesion between cells, hydration or body sites [40]. This technique has
been used for evaluation of the barrier function of skin, i.e. for investigating the depth of
penetration of drugs [41], the influence of drug enhancers on stratum corneum [42], pH profiles
[43] and many others. The tape stripping test (TST) is a representative method for estimating
the barrier performance of skin and other properties of the stratum corneum [44]. When the
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Scotch tape is placed on skin and peeled off, stratum corneum layer is stuck to the surface of
the tape. Therefore, the barrier performance is decreased. Attenuated total reflection-Fourier
transform infrared spectroscopy (ATR-FTIR) is an effective method when a material which is
not well transmissive is measured, and the method can be used for liquid or solid samples.
The information tells us about several micrometres of surface; thus, it is also a useful method
for analysing skin [45, 46]. ATR-FTIR spectra can give us information about hydration of skin
[47], structure of proteins [48] and lipids [49] and about their changes during skin treatment
by chemical or other drug enhancers [50, 51]. There are several vibrational bands associated
with chemical functional groups. Vibrational bands at 2850 and 2920 cm−1 belong to CH2
symmetric and asymmetric stretching modes, respectively [52]. The absorbance of the
spectrum decreases as the thickness of the skin decreases and the wavenumber indicates a
change in chain conformation, especially a change in peak shape [49].
5. Introduction to chemical and physical transdermal drug delivery
methods
The stratum corneum provides a barrier to any chemical entering the body and only small
molecules having a molecular weight of less than 500 Da (Daltons) can passively diffuse
through the skin at rates resulting in therapeutic effects. There are several methods for
overcoming this barrier such as using chemical enhancers or physical ways using electric
current or plasma discharge.
5.1. Chemical enhancers in transdermal drug delivery
Chemical enhancers are substances that change properties of skin for better penetration of
drugs. The most well-known chemical enhancers are alcohols, fatty acids, terpenes and
azone. An increase in permeability is very often caused by fluidising the lipids in stratum
corneum. However, it is not valid for high concentration of short chain alcohols (like etha-
nol), where there was observed only a decrease of the absorbance of CH2 stretching bands
and no shift of their position; thus, there is only the extraction of lipids [53]. Many enhanc-
ers have long hydrocarbon chains, and it was found out that for fatty acids and fatty alco-
hols, enhancement is related to the length of the hydrophobic group chain [32]. Enhancer
can interact with polar head or with hydrophobic tails of lipid bilayer or with proteins. Wa-
ter increases fluidity of stratum corneum by insertion of water molecules between polar
head groups. Dimethylsulfoxide (DMSO) interacts with intercellular lipids and keratin.
Azone disrupts lipid structure, and oleic acid increases fluidity of intercellular lipids. The
most effective enhancers are those which interact with lipids and also with proteins of stra-
tum corneum [54]. Combinations of chemical enhancers have been used to maximize the
effect of the permeability of drugs, and chemical enhancers are also combined with physical
enhancing methods such as iontophoresis [55].
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5.2. Iontophoresis in transdermal drug delivery
Iontophoresis (Figure 2) is a class of noninvasive methods to increase penetrations of ions
through the skin by applying electric current using low voltages of up to 10 V (Figure 2).
Figure 2. Application of iontophoresis to skin.
Various waveforms of applied current have been investigated [56], and it has been shown that
various waveforms have various effectivities for skin permeability [57]. Iontophoresis enhan-
ces transdermal drug delivery by three mechanisms:
1. Ion-electric field interaction causing moving of drug (ions) away from the electrode
through the skin.
2. Flow of electric current increases skin permeability.
3. Electro-osmosis caused by solvent flow from the anode to cathode because of negatively
charged skin due to amino acids in cell membranes.
Iontophoresis is used for ionisable drugs, and it is most effective for molecules with weight of
up to 7 kDa [58] or 10–15 kDa according to Kalluri and Banga [59]. The disadvantages of
iontophoresis are: difficulties with stabilizing the therapeutic agent in the application vehicle,
complexity of the drug release system and prolonged skin exposure to an electric current [60].
The main changes on skin after iontophoresis are an increase of the hydration of stratum
corneum and a decrease of electrical resistance of the skin [61]. Analysis of asymmetric CH2
peak, in ATR-FTIR spectra, did not show lipid alkyl chain disorders characterised by band
shift or band broadening even at high current densities in some previous works [61–64]. On
the other hand, in the recent work of Prasad et al. [65], they observed a shift of asymmetric
CH2 band with increasing of current density that achieved 8 cm−1 at 0.2 mA/cm2. Also decreas-
ing of lipid and protein bands intensity indicates lipid and protein extraction. The spectra also
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demonstrated a split in amide II band into 1553 and 1541 cm−1. The split could be due to the
disruption in hydrogen bonding associated with the head of ceramides, breaking interlamellar
hydrogen bonding of the lipid bilayer and disrupting the barrier property of stratum corneum,
resulting in loosening of lipid-protein domains, thus allowing higher flux as compared to the
passive treatment [65]. Reversibility studies were conducted in vivo after 24 and 48 h of the
application of iontophoresis. It was observed that the recovery process had started in 24 h and
almost total recovery of epidermal as well as dermal changes was found in 48 h with low
current density DC iontophoresis. However, with iontophoresis using 0.5 mA/cm2 current
density, edema along with focal disruption of the epidermis persisted [65].
5.3. Electroporation in transdermal drug delivery
Unlike iontophoresis, electroporation (Figure 3) uses high voltage (HV) (over 100 V) pulses
for short time (in range of microseconds to milliseconds). Cells exposed to an electrical pulse
open pores in the cell membrane and allow macromolecules to enter. It was confirmed that
delivery of drugs of at least 40 kDa can be achieved [66]. The disadvantages of electroporation
are as follows: (1) if the pulses have not adequate length and intensity, pores can be too large
or cause cell damage, non-specific amount of material can be released to the cell [67]. (2) The
created pores can persist for several hours, which allow a higher amount of drug to be
delivered [30].
Figure 3. Application of electroporation application.
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6. Plasma sources used for skin treatment
Several kinds of plasma sources were used for investigation of transdermal drug delivery so
far, such as volume dielectric barrier discharge (DBD), surface DBD and plasma jet.
6.1. Volume DBD
Volume DBD (Figure 4) with one isolated electrode has been used in the study of Kalghatgi
et al. [68]. Plasma can be with direct contact with a treated object (placed between electrodes)
but with increasing distance of electrodes, ignition voltage also increases, too. This means that
very high voltages need to be used in real applications. Kalghatgi et al. used pulsed discharge
with a pulse duration of 1–10 μs. They applied 10 kV in the frequency range of 50–3.5 kHz to
HV electrode isolated by quartz glass. The skin was treated from 15 to 120 s.
Figure 4. Volume dielectric barrier discharge.
6.2. Surface DBD
Another version of DBD is surface DBD used in Shimizu et al. [23, 69]. Both electrodes were
in contact with isolator layer. Each electrode had a thickness in micrometre dimensions. These
low dimensions allowed the decrease of ignition voltage to hundreds of volts. During treat-
ment of skin, electrodes were powered by 600 V with an AC frequency of 27 kHz. Electrodes
are created by two copper grids each with a thickness of 18 μm with insulation layer between
them with thickness of 100 μm. The high-voltage electrode was covered with an insulation
layer and the grounded electrode faced the skin samples at a distance of approximately 1.5
mm (Figure 5). Thus, there was no risk of electric shock to users, even when touching the
surface of the film electrode. The waveform of the applied voltage and corresponding dis-
charge current are shown in Figure 5. Holes between electrode lines allowed gas to pass
towards the sample (Figures 5 and 6). Argon gas was supplied to the microplasma electrode
systems with a flow rate of 5 L/min through the tube that was connected to the electrode. The
exposure time was usually between 1 and 5 min (Figure 7).
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Figure 5. Top view of microplasma electrode, before discharge (left), discharge with Ar gas – 600 V (right) [69].
Figure 6. Cross section of microplasma electrode (left); waveforms of microplasma discharge (right) [69].
Figure 7. Experimental set-up with microplasma electrode [23].
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6.3. Plasma jet
Plasma jets consist usually from a gas nozzle with one, two or three electrodes [70, 71]. The
plasma jet can be realised by two ways—active plasma jets (expanding plasma contains free
and high energetic electrons) and remote plasma jets (plasma is potential free and consists
of relaxing and recombining active species from inside the nozzle) [70]. The plasma jet in
Figure 8 consists of a Pyrex tube and a central tungsten high voltage (HV) electrode. The
grounded electrode is an aluminium ring located at the end of the outer surface of the Pyrex
tube. The distance between the skin sample and the outlet of the plasma jet was set to 2 mm.
The sample was isolated from the holder by a 30-mm thick PVC isolator or without isolator
to compare the effect of the conductive layer under the skin surface as the human body is
not isolator. The treatment time of the sample was set from several seconds to 1 min. Argon,
nitrogen or argon-water vapour gases were introduced into the plasma jet. The waveform of
the voltage and current of argon plasma jet is depicted in Figure 8 [72].
Figure 8. Waveform of plasma jet discharge (left) [72] and plasma jet electrode (right).
7. Plasma effects on skin barrier and transdermal drug delivery
7.1. Chemical reactions plasma particles with the skin
If argon plasma is used for skin treatment, the plasma produces electrons, argon ions, meta-
stable and excited states. These particles can react with the skin directly. But, if argon or
nitrogen plasma is working in atmospheric air, it makes the situation more complex because
molecules of air (O2, N2, CO2 and H2O) can enter the volume of the plasma jet [73, 74]. In this
case, argon can react with skin also indirectly through the excitation or dissociation or
ionization process with air molecules. The reaction results in the creation of a number of
species. It is difficult to find the molecule causing changes in skin. Pig skins treated by argon,
nitrogen and argon/water plasma were compared by measuring ATR-FTIR spectra and
monitoring of the shift of asymmetric stretching CH2 band near 2920 cm−1. A comparison of
argon and nitrogen plasma jets has shown that argon can play a role in reactions with molecules
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of stratum corneum, but a similar effect can be achieved by nitrogen plasma itself as similar
shift can be observed. A significantly higher value of shift was observed when argon with water
vapours was used. The asymmetric stretching band was shifted 3.5 cm−1 (Figure 9). This result
indicates that the stratum corneum became the most permeable after treatment of Ar plasma
with water vapours. On the other hand, we observed low wavenumber shifts of the maxima
of amide I and amide II (Figure 9).
Figure 9. Shift of asymmetric stretching band of CH2 to higher wavenumbers for the gases used in plasma jet dis-
charge. Flow 10 L/min = (Ar*; N2), 3 L/min = (Ar; Ar+H2O).
Pig skin treated by argon microplasma shows shift of asymmetric stretching CH2 band near
2920 cm−1 after 1, 3 and 5 min of irradiation comparable with the plasma jet (Figure 10).
Figure 10. Shift of asymmetric stretching band of CH2 to higher wavenumbers for Ar gas after microplasma irradiation
[69].
Enhancement of Percutaneous Absorption on Skin by Plasma Drug Delivery Method
http://dx.doi.org/10.5772/65116
121
When argon flew through the water reservoir, the argon ensured a higher concentration of
water vapours in the discharge. The high shift of the asymmetric stretching band of CH2
indicates that H2O and the created OH molecules can play important roles in increasing the
shift of the asymmetric stretching band of CH2 in stratum corneum. OH could be created
mainly by two channels [75]:
2mAr H O OH H Ar+ ® + + (1)
2H O e OH H e+ ® + + (2)
Simulation of the interaction of O and OH radicals with α-linolenic acid as a representative
of fatty acid [76] showed that OH radicals most typically abstract an H atom from the fatty
acids, which can lead to the creation of a double bond and also to the incorporation of alco-
hols or aldehyde groups, increasing hydrophilic properties of fatty acids and changing the
lipid composition of the skin, causing an increase of skin permeability. Creation of these
groups increases the hydrophilic character of the lipid layer. Incorporation of oxygen to stra-
tum corneum lipids was also confirmed by increasing of C–O and C=O bonds after treat-
ment of skin layer by atmospheric plasma [77]. Also, micropores (10 nm–1 μm in size) were
observed in an artificial cell membrane system consisting of supported lipid bilayers after
DBD plasma irradiation [78]. Later, it was found out that these micropores are induced tran-
sient species such as OH and OOH formed by plasma and they caused lipid peroxidation
leading to truncated lipid chains, which induced pore formation [79]. These temporal pores
were observed in skin after DBD plasma treatment and it was allowed to penetrate large
molecules through the skin in several minutes. These pores had lifetimes of less than 5 min
after treatment [68].
7.2. Effect of heating on skin barrier
Heating of the skin can increase permeability of stratum corneum [80]. Reasons of improving
of transdermal delivery through the skin by increasing temperature are structural changes of
stratum corneum lipids. Plasma can raise skin temperature from 30°C to more than 100°C
which depends on the irradiated time, power of plasma source or used gas. Structural changes
of stratum corneum lipids occur between 20 and 40°C, from orthorhombic to hexagonal
ordered lipids. These changes can be indicated by CH2 symmetric stretching frequency with
an increase of 0.5 cm−1 in ATR-FTIR spectra or it is possible to observe by CH2 scissoring mode
where transition is revealed by splitting of the scissoring modes to produce a doublet with
components at 1473 and 1463 cm−1. Ordered lipid chains change to disordered chains at around
80–90°C. But some scientific groups identified more transitions in lipid structure [52]. For
example, four phase transitions in temperature ranges 35–42°C, 65–75°C, 78–86°C and 90–
115°C, respectively. Transitions below 75°C are reversible [81]. Between 35°C and 42°C two
transitions can occur belonging to solid fluid transition and disruption of lipids covalently
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linked to corneocites at 37 and at 40°C to ‘orthorhombic to hexagonal’ change in structure. But
too high a temperature can cause damage to the skin. Thermal conditions that cause burns of
the skin are functions of the time and method of how the skin is exposed to the heat. Longer
exposure of skin to a temperature higher than 43°C can lead to the formation of blisters [82].
It was found out that fast heating of skin can increase skin permeability without damaging
deeper tissues. Investigation of high temperatures of up to 315°C applied to skin for 100 ms,
1 s and 5 s showed small variations between drug deliveries of calcein [82]. Exposure for 1 s
or 5 s should be sufficient to equalize temperature in the full thickness of skin, but the 100 ms
exposure should have influence only on stratum corneum. Between 100 and 150°C, permea-
bility of skin was increased a few fold. This increase was attributed to lipid melting in the
stratum corneum. In the range of 150–250°C, transdermal flux increased by two orders,
attributable to disruption of stratum corneum keratin network structure. Above 300°C,
transdermal flux increased by three orders, attributable to decomposition and vaporization of
the stratum corneum [83].
7.3. Effect of UV radiation on skin barrier
The wavelength range of 100–400 nm is called UV light and is usually divided into three ranges:
UVA (320–400 nm), UVB (280–320 nm) and UVC (100–280 nm). UV light can cause damage to
skin. It is well-known that atmospheric plasma can generate wide range of UV light dependent
on the used gas [84, 85]. UVC radiation can reach only stratum corneum and it consists of
emission of excited NO molecule (200–280 nm—NO-gama system) or nitrogen molecule (120–
200 nm—LBH system) in plasma discharges. The source of UVB radiation is emission of OH
and nitrogen (second positive system of nitrogen). UVA is composed mostly of second positive
system of nitrogen. UVA and UVB can reach deeper layers of skin like epidermis and UVA
also dermis. UV radiation can cause formation of hydroxides and epoxides, hydrogenation of
double bonds and breaking of carbon chains. The effect of UV on lipids depends on their
structure, and only double bonds of fatty acids are sensitive to the formation of oxygenated
molecules by oxygen in the air. These changes can be amplified or weakened by the surround-
ing atmosphere around the treated skin. When lipids of stratum corneum like cholesterol,
cholesterol sulphate, ceramide III, linolenic acid and dipalmitoylphosphatidylcholine were
irradiated by UV light up to 240 min, peroxidative changes occurred only in lipids with double
bonds such as cholesterol and linolenic acid [86]. But the changes are not permanent and the
order of stratum corneum lipids and water-loss protection can recover after 3 days and it
returns to its initial state, thanks to repair processes in the skin [87]. Reactive oxygen species
like superoxide anion radicals, singlet oxygen, hydrogen peroxide and hydroxyl radical can
be created by UV light. For example, superoxide anion radicals are precursors to other oxygen
reactive species, and it was found that there exists a correlation between the superoxide anion
radical’s concentration and degree of oxidation of lipids [88]. UV light is also used for treatment
of some skin diseases but delivered doses have to be controlled and maintained in safety level
to not penetrate to deeper layers of skin [89].
Enhancement of Percutaneous Absorption on Skin by Plasma Drug Delivery Method
http://dx.doi.org/10.5772/65116
123
7.4. Acidifying effect of plasma on skin
Acidifying effect was observed after applying plasma to stripped lipids from stratum corneum.
A higher decrease of pH was observed in discharges, which produced a higher amount of
NOx species. The same effect was observed on human skin, but after 30 min after plasma
treatment, the pH of skin return to initial value [90]. The decrease of pH depends on parameters
of the plasma discharge and the treatment time. Previous work has attributed the pH shift of
water on plasma-treated lipids to the interaction of reactive species with the surface. Nitrates
formed in water droplets could form nitric acid. NOx species could adhere on lipid surface or
deposited nitric acid on the film surfaces by gaseous HNO3 [91]. The recovery of pH in the
post-plasma phase was attributed to the decrease of acidifying agents on the substrate surfaces
by both diffusion and desorption processes.
7.5. Skin etching and skin damage by plasma
The etching effect of plasma is demonstrated in Figure 11 by a cross section of the skin. The
stratum corneum layer (the white part in (a) control sample) was removed after 20 tape
stripping cycles, as shown in (b). After 30 s of atmospheric plasma jet irradiation, most of the
stratum corneum layer was removed, as shown in (c). In the microplasma case, even after 5
min irradiation (d), the stratum corneum layer remained similar to the control sample, as
shown in (a) [23]. Little difference in physical appearance was observed between the control
pig skin sample and after microplasma irradiation. For the tape stripping test, surface asperity
was decreased and after 10 s of atmospheric plasma jet irradiation, small pores (ranging from
40 to 100 μm) were observed. Physical damages on skin could be considered to arise from the
electric field or an etching effect from bombardment with charged particles [92].
Surface potential can lead to a strong electric field across the skin and finally penetrate the skin
to form holes. Holes were confirmed after longer operation (3–5 min) of atmospheric plasma
irradiation. Pores and holes are shown in Figure 12 after 10 and 30 s of operation of the plasma
jet.
This physical damage could affect the barrier function of skin samples. When the effect of
plasma jet was tested on PEN film, after 10 s of plasma jet irradiation, the surface potential
increased to about 10% of the driven voltage. After long-term operation, it reached almost the
same value as the driven voltage [23]. A similar problem could happen in electroporation but
it uses very short operation times in the range of microseconds or milliseconds. High surface
potential can induce current flow through the skin and it will increase the skin temperature
and might affect cells of skin and cause thermal damage of skin [93]. On the contrary, the surface
potential remained low in the microplasma case. The thickness of stratum corneum after 30 s
of treatment of plasma jet is equivalent to 20 times of striping by tape. This is also confirmed
by TEWL (Figure 13), which also shows the same values. On the other hand, TEWL after 5 min
of microplasma irradiation of the pig skin sample, TEWL increased to almost double its original
value, suggesting that the barrier properties were decreased through atmospheric microplas-
ma irradiation but it is less effective than plasma jet [23].
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Figure 11. Cross section of pig skin after atmospheric plasma irradiation, and tape stripping test. (a) Control sample,
stratum corneum thickness: 18.09 ± 1.64 μm; (b) tape stripping test — 20 times, stratum corneum thickness: 5.99 ± 1.24;
(c) plasma jet — 30 s, stratum corneum thickness: 3.49 ± 0.61; (d) microplasma — 5 min, stratum corneum thickness:
13.40 ± 1.46 [72].
Figure 12. Left: 10 s of treatment by plasma jet; Right: 30 s of treatment by plasma jet [72].
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Figure 13. Variations of TEWL values before and after microplasma irradiation, tape striping test and plasma jet irradi-
ation [72].
8. Improvement of galantamine hydrobromide (GaHBr) permeation by
plasma irradiation
Galantamine hydrobromide (GaHBr) (Figure 14) is an alkaloid, isolated from plant species
such as Narcissus and Lycoris species [93]. Treatment of Alzheimer’s disease occurs by
inhibition of acetylcholinesterase enzyme. The chemical structure of galantamine hydrobro-
mide is shown in Figure 14.
Figure 14. Chemical structure of galantamine hydrobromide.
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As GaHBr is a hydrophilic molecule with a low molecular weight (368 Da), usually transdermal
patches with chemical enhancers are used for transdermal delivery [94]. Using microplasma
for the first time for enhancement of transdermal delivery of GaHBr, a slight improvement was
observed with comparison of passive diffusion (Figure 15). Pig skin was irradiated for 3 min
and then a water solution with GaHBr was applied on the skin. The permeation profiles of
GaHBr through the pig skin delivered 5.35 ± 2.34 and 11.53 ± 2.89 μg/cm2 for the control and
the plasma-irradiated sample 24 h post-experiment, respectively [69]. These results lead to the
expectation that microplasma discharge can be used to enhance the skin delivery of hydro-
philic drugs and larger molecular drugs in the future.
Figure 15. Amount of penetrated GaHBr—passive diffusion and after microplasma irradiation (red circles) [69].
9. Outlook of plasma drug delivery
Plasma as a source of UV light, heat, ions, reactive radicals and metastable states could be a
successful tool for transdermal drug delivery. Each of these parameters can be used for
improvement of skin permeability. Stratum corneum can be altered by chemical reaction of
reactive oxygen species or by UV causing peroxidation of intercellular lipids. Undesirable
heating effects can be tuned by the length of the plasma pulse and then a change of the
conformation of lipids can be achieved also by increasing gas temperature in plasma. Im-
provement of permeability of skin by plasma was proved by ATR-FTIR and TEWL methods.
A plasma jet is effective in etching of stratum corneum but can cause damage to skin because
of the presence of a high electric field. We believe that plasma jet could be considered as a
trade-off relationship, i.e. accompanied by physical damage or pain on the skin, similar to
needles and creation of pores can cause risk of infection. On the other hand, microplasma seems
to be more suitable for future drug delivery because it caused lower damage of skin. Trans-
dermal drug delivery of galantamine hydrobromide by microplasma showed slight improve-
ment in comparison with passive diffusion but further investigation is needed for drug testing
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or improvement in plasma properties in the future. We suggest that the use of a transdermal
drug delivery with plasma irradiation is feasible, and thus, could be combined with appro-
priate drugs to target various symptoms such as Alzheimer’s disease, diabetes and other
symptoms that cannot be cured by applying plasma irradiation alone. This novel method will
reveal new directions for the future of plasma medicine. Our aim is to combine a safe trans-
dermal drug delivery method with a transdermal agent such as a peptide vaccine without
requiring an injection needle and causing physical damage to the skin. Safety of patients,
without causing harmful damage or physical damage to the skin, is critical for enabling this
novel technology.
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